CCL20 and Familial prostate cancer: 1. Preclinical studies establish SCFAs from Castration-Resistant Prostate Cancer-associated microbiota as key mediators linking dysbiosis to tumor progression;2. CCL20 identified as a potential prognostic biomarker for prostate cancer.